-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $17

Benzinga·08/17/2026 12:56:26
Listen to the news
Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:LONA) with a Market Outperform and lowers the price target from $18 to $17.